Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H38N.Br |
Molecular Weight | 384.437 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1
InChI
InChIKey=KHSLHYAUZSPBIU-UHFFFAOYSA-M
InChI=1S/C21H38N.BrH/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21;/h13-15,17-18H,4-12,16,19-20H2,1-3H3;1H/q+1;/p-1
Molecular Formula | BrH |
Molecular Weight | 80.912 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C21H38N |
Molecular Weight | 304.5331 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Benzododecinium, a quaternary ammonium compound, is an antiseptic agent and disinfectant. Benzododecinium is used as preservative in different pharmaceutical formulations. Thus, the dispenser of Timoptol-LA, used for the treatment of patients with ocular hypertension, contains benzododecinium bromide as a preservative. It is used as preservative and the corneal permeability enhancer in formulation. Benzododecinium is effective against gram-positive microbes.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL613321 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29175345 |
|||
Target ID: CHEMBL612500 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21393196 |
PubMed
Title | Date | PubMed |
---|---|---|
Adverse drug reactions in Canada. Hematologic reactions to sterol and sterolin-containing products. | 2004 Aug |
|
Analysis of benzyldimethyldodecylammonium bromide in chemical disinfectants by liquid chromatography and capillary electrophoresis. | 2004 Jun 11 |
|
Water purification from organic pollutants by optimized micelle-clay systems. | 2005 Apr 1 |
|
[Preformulation studies of potential drug XIX M: partition coefficient]. | 2005 Mar |
|
Architecture of the hydrophobic and hydrophilic layers as found from crystal structure analysis of N-benzyl-N,N-dimethylalkylammonium bromides. | 2005 Oct 1 |
|
Identification of benzalkonium chloride in commercial grapefruit seed extracts. | 2005 Sep 21 |
|
Molecular mechanism and thermodynamics study of plasmid DNA and cationic surfactants interactions. | 2006 Apr 11 |
|
Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes. | 2006 Mar 27 |
|
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide I. Surface properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide. | 2009 Mar 15 |
|
Characterization of occupational exposures to cleaning products used for common cleaning tasks--a pilot study of hospital cleaners. | 2009 Mar 27 |
|
Synthesis of macroporous thermosensitive hydrogels: a novel method of controlling pore size. | 2009 Mar 3 |
|
Biofouling control using microparticles carrying a biocide. | 2010 |
|
Sorption of quaternary ammonium compounds to municipal sludge. | 2010 Apr |
|
The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections. | 2010 Dec |
|
Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface. | 2010 Dec |
|
Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension. | 2010 Jul 21 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30423418
Curator's Comment: The design proposed the optimized batch by selecting the independent variables as gellan gum (0.55% w/v), carbopol 934P (0.35% w/v) and benzododecenium bromide (0.013% w/v) to achieve the maximum viscosity
Ophthalmic use: The 25 uL of test sample was instilled in the lower conjunctival sac
of eye and holded for 10 seconds.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21393196
Curator's Comment: The mechanism of action of benzyldimethyldodecylammonium chloride (Benzododecinium chloride) was assessed against Pseudomonas fluorescens.
The MIC was found to be 20 mg/L and the MBC was 10 mg/L
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:57:27 GMT 2023
by
admin
on
Fri Dec 15 15:57:27 GMT 2023
|
Record UNII |
IRY12B2TQ6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
IRY12B2TQ6
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
7281-04-1
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
C76255
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
23705
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
230-698-4
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
IRY12B2TQ6
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
1311594
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID4048698
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
SUB00725MIG
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
100000085001
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
BENZODODECINIUM BROMIDE
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY | |||
|
167207
Created by
admin on Fri Dec 15 15:57:27 GMT 2023 , Edited by admin on Fri Dec 15 15:57:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |